Appropriate Medication Use

PQA Appropriate Medication Use Measures


The appropriate medication use measures focus on diabetes and anticoagulation. The Statin Use in Persons with Diabetes measure assesses the percentage of patients ages 40 to 75 years who were dispensed medications for diabetes and a statin medication. The Use of Medications to Prevent Major Cardiovascular Events in Persons with Diabetes measure assesses the percentage of individuals who have type 2 diabetes and established atherosclerotic cardiovascular disease that are prescribed a GLP-1 receptor agonist or SGLT-2 inhibitor with proven cardiovascular benefit. The International Normalized Ratio (INR) Monitoring for Individuals on Warfarin measure assesses the percentage of individuals who had at least one INR monitoring test during each 56-day interval with active warfarin therapy.

  • Statin Use in Persons with Diabetes (SUPD)
  • Use of Medications to Prevent Major Cardiovascular Events in Persons with Diabetes (CVDM)
  • International Normalized Ratio Monitoring for Individuals on Warfarin (INR)(NQF #0555)about PQA Measues
Download an Overview of PQA Measures
Ask about PQA Measures
Learn More about the PQA Measure Development Process

Updated March 5, 2021